MSN: Pabrinex intravenous and intramuscular (IM) injection

DHSC has issued a tier 3 medicine supply notification (MSN) for Pabrinex (vitamins B and C) intravenous and intramuscular high potency solution for injection ampoules.

Pabrinex IV injection will be out of stock from August 2024 until at least September 2025.
Pabrinex IM) injection is being discontinued, with stock exhaustion expected from December 2024.

There are no other licensed parenteral alternatives to Pabrinex IV and IM injections

Up-to-date information about medicine supply issues is available via the online Medicines Supply Tool.

Supply Shortages

Latest news

DDA meets MPs to discuss increasing cost pressures

The increasing cost pressures on dispensing practice have been highlighted by the DDA in a drop-in meeting with cross party MPs. Facilitated by Labour MP (Buckingham & Bletchley) Callum Anderson, the meeting saw DDA senior leaders meet with MPs

Rising dispensing GP cost pressures recognised by CMO

The chief medical officer (CMO) for England has recognised the increased cost pressures on dispensing practices in his latest report, Health in rural areas and small towns. The report stresses that practices are closing or reducing their vital servi

England & Wales: Initial November concession prices

The Department of Health and Social Care has published an initial list of November concessions for England and Wales. Details of the update are available in a downloadable spreadsheet for DDA members.